These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21330931)

  • 21. Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
    Sheiban I; Garrone P; Sillano D; Biondi-Zoccai G; Sciuto F; Omedè P; Lombardi P; Meliga E; Anselmino M; Trevi GP; Moretti C
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1246-53. PubMed ID: 19001932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of death in patients undergoing percutaneous coronary intervention with drug-eluting stents in a real-world setting.
    Lee MS; Canan T; Perlowski A; Bhatia R; Jurewitz D; Tobis JM
    J Invasive Cardiol; 2009 Sep; 21(9):441-5. PubMed ID: 19726814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents.
    De Felice F; Fiorilli R; Parma A; Nazzaro MS; Dibra A; Musto C; De Santis A; Violini R
    J Invasive Cardiol; 2008 Dec; 20(12):651-4. PubMed ID: 19057029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of interventional treatment of stress positive coronary artery disease.
    Adamu U; Knollmann D; Alrawashdeh W; Almutairi B; Deserno V; Kleinhans E; Schäfer W; Hoffmann R
    Am J Cardiol; 2010 Jun; 105(11):1535-9. PubMed ID: 20494657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention.
    Zhang RY; Zhu ZB; Zhang Q; Yang ZK; Hu J; Lv AK; Zhang JS; Shen WF
    Int J Cardiol; 2009 Jul; 136(1):72-9. PubMed ID: 18653250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.
    Wu XM; Liu CP; Lin WC; Kao HL
    Int J Cardiol; 2010 Feb; 138(3):272-6. PubMed ID: 18804295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry.
    Balducelli M; Ortolani P; Marzaroli P; Piovaccari G; Menozzi A; Manari A; Sangiorgio P; Tarantino F; Rossi R; Maresta A; Tondi S; Passerini F; Guastaroba P; Grilli R; Marzocchi A
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):327-34. PubMed ID: 19937776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL; Schaff HV
    Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology.
    Capodanno D; Tamburino C; Sangiorgi GM; Romagnoli E; Colombo A; Burzotta F; Gasparini GL; Bolognese L; Paloscia L; Rubino P; Sardella G; Briguori C; Ettori F; Franco G; Di Girolamo D; Sheiban I; Piatti L; Greco C; Petronio AS; Loi B; Lyoi E; Benassi A; Patti A; Gaspardone A; De Servi S;
    Circ Cardiovasc Interv; 2011 Feb; 4(1):72-9. PubMed ID: 21205940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention.
    Nair S; Fath-Ordoubadi F; Clarke B; El-Omar M; Foley J; Fraser DG; Mahadevan VS; Neyses L; Khattar RS; Mamas MA
    EuroIntervention; 2011 Mar; 6(8):985-91. PubMed ID: 21330247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.